PURPOSE: A poorly water soluble acidic active pharmaceutical ingredient (API) was transformed into an ionic liquid (IL) aiming at faster and higher oral availability in comparison to a prodrug. METHODS: API preparations were characterized in solid state by single crystal and powder diffraction, NMR, DSC, IR and in solution by NMR and ESI-MS. Dissolution and precipitation kinetics were detailed as was the role of the counterion on API supersaturation. Transepithelial API transport through Caco-2 monolayers and counterion cytotoxicity were assessed. RESULTS: The mechanism leading to a 700 fold faster dissolution rate and longer duration of API supersaturation of the ionic liquid in comparison to the free acid was deciphered. Transepithelial transport was about three times higher for the IL in comparison to the prodrug when substances were applied as suspensions with the higher solubility of the IL outpacing the higher permeability of the prodrug. The counterion was nontoxic with IC50 values in the upper μM / lower mM range in cell lines of hepatic and renal origin as well as in macrophages. CONCLUSION: The IL approach was instrumental for tuning physico-chemical API properties, while avoiding the inherent need for structural changes as required for prodrugs.
PURPOSE: A poorly water soluble acidic active pharmaceutical ingredient (API) was transformed into an ionic liquid (IL) aiming at faster and higher oral availability in comparison to a prodrug. METHODS: API preparations were characterized in solid state by single crystal and powder diffraction, NMR, DSC, IR and in solution by NMR and ESI-MS. Dissolution and precipitation kinetics were detailed as was the role of the counterion on API supersaturation. Transepithelial API transport through Caco-2 monolayers and counterion cytotoxicity were assessed. RESULTS: The mechanism leading to a 700 fold faster dissolution rate and longer duration of API supersaturation of the ionic liquid in comparison to the free acid was deciphered. Transepithelial transport was about three times higher for the IL in comparison to the prodrug when substances were applied as suspensions with the higher solubility of the IL outpacing the higher permeability of the prodrug. The counterion was nontoxic with IC50 values in the upper μM / lower mM range in cell lines of hepatic and renal origin as well as in macrophages. CONCLUSION: The IL approach was instrumental for tuning physico-chemical API properties, while avoiding the inherent need for structural changes as required for prodrugs.
Authors: Chantal Masungi; Caroline Borremans; Bart Willems; Jurgen Mensch; Alex Van Dijck; Patrick Augustijns; Marcus E Brewster; Mark Noppe Journal: J Pharm Sci Date: 2004-10 Impact factor: 3.534
Authors: Manuel Koller; Kurt Lingenhoehl; Markus Schmutz; Ivan-Toma Vranesic; Joerg Kallen; Yves P Auberson; David A Carcache; Henri Mattes; Silvio Ofner; David Orain; Stephan Urwyler Journal: Bioorg Med Chem Lett Date: 2011-04-08 Impact factor: 2.823
Authors: David Orain; Silvio Ofner; Manuel Koller; David A Carcache; Wolfgang Froestl; Hans Allgeier; Vittorio Rasetti; Joachim Nozulak; Henri Mattes; Nicolas Soldermann; Philipp Floersheim; Sandrine Desrayaud; Joerg Kallen; Kurt Lingenhoehl; Stephan Urwyler Journal: Bioorg Med Chem Lett Date: 2011-12-08 Impact factor: 2.823
Authors: Baltazar Gomez-Mancilla; Ronald Brand; Tim P Jürgens; Harmut Göbel; Claudia Sommer; Andreas Straube; Stefan Evers; Martin Sommer; Victor Campos; Hans O Kalkman; Sam Hariry; Nicole Pezous; Donald Johns; Hans-Christoph Diener Journal: Cephalalgia Date: 2013-08-20 Impact factor: 6.292
Authors: Ksenia S Egorova; Marina M Seitkalieva; Alexandra V Posvyatenko; Victor N Khrustalev; Valentine P Ananikov Journal: ACS Med Chem Lett Date: 2015-09-28 Impact factor: 4.345
Authors: Anthony Lai; Nathania Leong; Dan Zheng; Leigh Ford; Tri-Hung Nguyen; Hywel D Williams; Hassan Benameur; Peter J Scammells; Christopher J H Porter Journal: Pharm Res Date: 2022-06-03 Impact factor: 4.580